1999
DOI: 10.1016/s0021-9150(99)00105-7
|View full text |Cite
|
Sign up to set email alerts
|

Coronary C-reactive protein distribution: its relation to development of atherosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
101
1
4

Year Published

2002
2002
2023
2023

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 178 publications
(112 citation statements)
references
References 24 publications
5
101
1
4
Order By: Relevance
“…IL-6 is a pleiotropic cytokine and central mediator of the acute-phase response and has a broad range of effects on diverse immune cells such as vascular endothelial cells, smooth muscle cells and leucocytes. 10 IL-6 11,12 and CRP [13][14][15] are also expressed in human atherosclerotic lesions.…”
Section: Introductionmentioning
confidence: 99%
“…IL-6 is a pleiotropic cytokine and central mediator of the acute-phase response and has a broad range of effects on diverse immune cells such as vascular endothelial cells, smooth muscle cells and leucocytes. 10 IL-6 11,12 and CRP [13][14][15] are also expressed in human atherosclerotic lesions.…”
Section: Introductionmentioning
confidence: 99%
“…Poor glycaemic control and long-term diabetic complications are associated with endothelial dysfunction, which promotes adherence of leucocytes to the vessel walls and induces inflammatory response [3,4]. In ad-dition, to reflect the continuous inflammatory process, CRP may be directly related to the development of atherosclerosis [5]. Diabetic patients usually have increased hsCRP concentrations [6].…”
Section: Introductionmentioning
confidence: 99%
“…Such a tight association between CRP levels and progression of the disease implies that CRP is not simply a sensitive marker but a direct mediator of CVD. Indeed, CRP can be detected in early lesions of atherosclerosis in humans [20] and its staining intensity correlates with disease development [21]. Moreover, CRP co-localizes with atherogenic mediators, including modified low density lipoproteins (LDL) [22,23], activated complement [24] and foam cells [20].…”
Section: The Controversial Role Of Crp In Atherosclerosismentioning
confidence: 99%